4613347658

McCreedy, and Lyles, D.S. (1989). Distribution of M protein and nucleocapsid protein of vesicular stomatitis virus in infected celi plasma membranes. Virus Res. 14, 189-205.

Mirę, C.E., Dube, D., Delos, S.E., White, J.M., and Whitt, M.A. (2009). Glycoprotein-Dependent Acidification of Vesicular Stomatitis Vims Enhances Release of Matrix Protein. J. Virol. 83, 12139-12150.

Petersen, J.M., Her, L.S., Varvel, V., Lund, E., and Dahlberg, J.E. (2000). The matrix protein of vesicular stomatitis virus inhibits nucleocytoplasmic transport when it is in the nucleus and associated with nuclear porę complexes. Molecular Celi Biology 20, 8590-8601.

Roche, S., Bressanelli, S., Rey, F.A., and Gaudin, Y. (2006). Crystal Structure of the Low-pH Form of the Vesicular Stomatitis Virus Glycoprotein G. Science 313, 187-191.

Roche, S., Rey, F.A., Gaudin, Y., and Bressanelli, S. (2007). Structure of the Prefusion Form of the Vesicular Stomatitis Vims Glycoprotein G. Science 315, 843-848.

Rosę, J.K., and Whitt, M.A. (2001). Rhabdoviridae: the viruses and their replication. In: Knipe D.M., Howley P.M. (eds). Fields Virology, 4th edn (Philadelphia).

Schincariol, A.L., and Howatson, A.F. (1970). Replication of vesicular stomatitis virus : I. Viral specific RNA and nucleoprotein in infected L cells. Virology 42, 732-743.

Schuler, L., Daura, X., and van Gunsteren, W. (2001). An improved GROMOS96 force field for aliphatic hydrocarbons in the condensed phase. Journal of Computational Chemistry 22, 1205-1218.

Schwartz, J.A., Buonocore, L., Suguitan, A.L., Jr., Silaghi, A., Kobasa, D., Kobinger, G., Feldmann, H., Subbarao, K., and Rosę, J.K. (2010). Potent Vesicular Stomatitis Virus-Based Avian Influenza Vaccines Provide Long-Term Sterilizing Immunity against Heterologous Challenge. J. Virol. 84,4611-4618.

Stark, G.R., Kerr, I.M., and Williams, B.R. (1998). How cells respond to interferons. p. 221.

Stojdl, D.F., Lichty, B., Knowles, S., Marius, R., Atkins, H., Sonenberg, N., and Bell, J.C. (2000). Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus. Nat. Med. 6, 821-825.

Stojdl, D.F., Lichty, B.D., tenOever, B.R., Paterson, J.M., Power, A.T., Knowles, S., Marius, R., Reynard, J., Poliquin, L., Atkins, H., et al. (2003). VSV strains with defects in their

91